SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-012386
Filing Date
2022-03-31
Accepted
2022-03-31 18:46:56
Documents
2
Period of Report
2022-03-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1527
2 EXHIBIT 24 brhc10035954_ex24.htm EX-24 9698
  Complete submission text file 0001140361-22-012386.txt   12800
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1028 CHAMBERS COURT BRIDGEWATER NJ 08807
Business Address
KANGO SUJAY (Reporting) CIK: 0001336503 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-31141 | Film No.: 22794975